Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -337,708 | -261,704 | -173,599 | -81,387 | -341,973 |
| Depreciation Amortization | -6,851 | -6,004 | -4,193 | -2,270 | -5,494 |
| Accounts receivable | N/A | N/A | N/A | N/A | 306 |
| Accounts payable and accrued liabilities | N/A | N/A | 16,418 | N/A | N/A |
| Other Working Capital | 14,620 | 13,171 | 20,822 | 7,978 | -32,458 |
| Other Operating Activity | 80,832 | 63,298 | 24,396 | 25,356 | 79,303 |
| Operating Cash Flow | $-249,107 | $-191,239 | $-116,156 | $-50,323 | $-300,316 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 611,564 | 507,490 | 368,290 | 203,095 | 647,302 |
| PPE Investments | -2,018 | -2,018 | -1,791 | -1,780 | -4,126 |
| Purchase Of Investment | -650,629 | -575,553 | -310,418 | -190,784 | -385,542 |
| Investing Cash Flow | $-41,083 | $-70,081 | $56,081 | $10,531 | $257,634 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 270,153 | 269,353 | 50,464 | 48,922 | 34,753 |
| Financing Cash Flow | $270,153 | $269,353 | $50,464 | $48,922 | $34,753 |
| Beginning Cash Position | 146,443 | 146,443 | 146,443 | 146,443 | 154,372 |
| End Cash Position | 126,406 | 154,476 | 136,832 | 155,573 | 146,443 |
| Net Cash Flow | $-20,037 | $8,033 | $-9,611 | $9,130 | $-7,929 |
| Free Cash Flow | |||||
| Operating Cash Flow | -249,107 | -191,239 | -116,156 | -50,323 | -300,316 |
| Capital Expenditure | -2,018 | -2,018 | -1,791 | -1,780 | -4,126 |
| Free Cash Flow | -251,125 | -193,257 | -117,947 | -52,103 | -304,442 |